Expression of ERCC1 protein in biopsy specimen predicts survival in advanced ovarian cancer patients treated with platinum-based chemotherapy.
第一作者:
M,Milovic-Kovacevic
第一单位:
Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. marijana@ncrc.ac.rs
作者:
医学主题词
青少年(Adolescent);成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);儿童(Child);儿童, 学龄前(Child, Preschool);DNA结合蛋白质类(DNA-Binding Proteins);内切核酸酶类(Endonucleases);女(雌)性(Female);人类(Humans);婴儿(Infant);中年人(Middle Aged);卵巢肿瘤(Ovarian Neoplasms);紫杉酚(Paclitaxel);预后(Prognosis);前瞻性研究(Prospective Studies);存活率(Survival Rate);治疗结果(Treatment Outcome);青年人(Young Adult)
PMID
22331726
发布时间
2015-11-19
- 浏览0
Journal of B.U.ON.
708-14页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



